...
首页> 外文期刊>Biochemical Pharmacology >Angiotensin-(1-9) reduces cardiovascular and renal inflammation in experimental renin-independent hypertension
【24h】

Angiotensin-(1-9) reduces cardiovascular and renal inflammation in experimental renin-independent hypertension

机译:血管紧张素 - (1-9)在实验性肾素独立高血压中降低心血管和肾炎

获取原文
获取原文并翻译 | 示例
           

摘要

Hypertension-induced cardiovascular and renal damage can be mediated by activation of the renin-angiotensin-aldosterone system. There are different factors beyond renin-angiotensin-aldosterone system involved in hypertension and renal damage. Inflammation has emerged as an important mediator of hypertension and cardiovascular and kidney damage. Angiotensin-(1-9), a peptide of the renin-angiotensin system, counter-regulates both the physiological and pathological actions of angiotensin II. Recent data has shown that angiotensin-(1-9) protects the heart and blood vessels from adverse cardiovascular remodeling in experimental models of hypertension and/or heart failure and reduces cardiac fibrosis in stroke-prone, spontaneously hypertensive rats. These effects are mediated by the angiotensin II type 2 receptor (AT2R). However, it remains unknown whether angiotensin-(1-9) also has an anti-inflammatory effect. In the present study, we investigate whether angiotensin-(1-9) reduces inflammation and fibrosis in the heart, arteries, and kidney in a DOCA-salt hypertensive model and explore the mechanisms underlying the amelioration of end-organ damage. DOCA-salt hypertensive rats received: a) vehicle, b) angiotensin-(1-9), c) PD123319 (AT2R blocker), d) angiotensin-(1-9) plus A779 (a Mas receptor blocker) or e) angiotensin-(1-9) plus PD123319, and sham rats were used as a control. Our results showed that angiotensin-(1-9) decreased hypertension and increased vasodilation in DOCA-salt hypertensive rats. These actions were partially inhibited by PD123319. Moreover, angiotensin-(1-9) decreased diuresis, fibrosis, and inflammation. These beneficial effects were not mediated by Mas or AT2R blockers. We concluded that angiotensin-(1-9) protects against volume overload-induced hypertensive cardiovascular and kidney damage by decreasing inflammation in the heart, aortic wall, and kidney, through mechanisms independent of the Mas or AT2R.
机译:高血压诱导的心血管和肾损伤可以通过肾素 - 血管紧张素 - 醛固酮体系的激活来介导。肾素 - 血管紧张素 - 醛固酮系统外,有不同的因素参与高血压和肾损伤。炎症已成为高血压和心血管和肾脏损伤的重要介质。血管紧张素 - (1-9),肾素 - 血管紧张素系统的肽,反调节血管紧张素II的生理和病理学作用。最近的数据表明,血管紧张素(1-9)保护心脏和血管免受高血压和/或心力衰竭的实验模型中的不良心血管重塑,并降低中风易患的心肌纤维化,自发性高血压大鼠。这些效果由血管紧张素II型受体(AT2R)介导。然而,血管紧张素 - (1-9)是否具有抗炎作用仍然未知。在本研究中,我们研究了血管紧张素 - (1-9)是否会降低心脏,动脉和肾脏中的炎症和纤维化,在Doca-盐高血压模型中,探讨终端器官损伤的改善的机制。接受Doca-盐高血压大鼠:a)载体,b)血管紧张素(1-9),c)pd123319(AT2R阻断),d)血管紧张素 - (1-9)加A779(MAS受体阻滞剂)或e)血管紧张素 - (1-9)加上PD123319,使用假大鼠作为对照。我们的研究结果表明,血管紧张素 - (1-9)降低了高血压和DOCA-盐高血压大鼠的血管舒张。通过PD123319部分抑制这些作用。此外,血管紧张素 - (1-9)降低了利尿,纤维化和炎症。这些有益效果未被MAS或AT2R阻滞剂介导。我们得出结论,血管紧张素 - (1-9)通过无关的机制可通过独立于MAS或AT2R的机制来防止体积过载诱导的高血压心血管和肾脏损伤。

著录项

  • 来源
    《Biochemical Pharmacology》 |2018年第2018期|共14页
  • 作者单位

    Advanced Center for Chronic Diseases (ACCDiS) Facultad de Medicina Pontificia Universidad;

    Departmento de Ciencias Basicas Biomedicas Facultad de Ciencias de la Salud Universidad de Talca;

    Division Enfermedades Cardiovasculares Escuela de Medicina Facultad de Medicina Pontificia;

    Advanced Center for Chronic Diseases (ACCDiS) Facultad de Medicina Pontificia Universidad;

    Division Enfermedades Cardiovasculares Escuela de Medicina Facultad de Medicina Pontificia;

    Advanced Center for Chronic Diseases (ACCDiS) &

    Centro de Estudios en Ejercicio Metabolismo y;

    Advanced Center for Chronic Diseases (ACCDiS) &

    Centro de Estudios en Ejercicio Metabolismo y;

    Advanced Center for Chronic Diseases (ACCDiS) &

    Centro de Estudios en Ejercicio Metabolismo y;

    Advanced Center for Chronic Diseases (ACCDiS) Facultad de Medicina Pontificia Universidad;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药理学;
  • 关键词

    Hypertension; Inflammation; Fibrosis; Renin-angiotensin system; Angiotensin-(1-9); AT2 receptor;

    机译:高血压;炎症;纤维化;肾素 - 血管紧张素系统;血管紧张素 - (1-9);AT2受体;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号